Cargando…

Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery

INTRODUCTION: Nanocarrier-based delivery systems offer multiple benefits to overcome limitations of the traditional drug dosage forms, such as protection of the drug, enhanced bioavailability, targeted delivery to disease site, etc. Nanocarriers have exhibited tremendous successes in targeted delive...

Descripción completa

Detalles Bibliográficos
Autores principales: Majumder, Joydeb, Minko, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904578/
https://www.ncbi.nlm.nih.gov/pubmed/32969740
http://dx.doi.org/10.1080/17425247.2021.1828339
_version_ 1783654958738964480
author Majumder, Joydeb
Minko, Tamara
author_facet Majumder, Joydeb
Minko, Tamara
author_sort Majumder, Joydeb
collection PubMed
description INTRODUCTION: Nanocarrier-based delivery systems offer multiple benefits to overcome limitations of the traditional drug dosage forms, such as protection of the drug, enhanced bioavailability, targeted delivery to disease site, etc. Nanocarriers have exhibited tremendous successes in targeted delivery of therapeutics to the desired tissues and cells with improved bioavailability, high drug loading capacity, enhanced intracellular delivery, and better therapeutic effect. A specific design of stimuli-responsive nanocarriers allows for changing their structural and physicochemical properties in response to exogenous and endogenous stimuli. These nanocarriers show a promise in site specific controlled release of therapeutics under certain physiological conditions or external stimuli. AREAS COVERED: This review highlights recent progresses on the multifunctional and stimuli-sensitive nanocarriers for targeted therapeutic drug delivery applications. EXPERT OPINION: The progress from single functional to multifunctional nanocarriers has shown tremendous potential for targeted delivery of therapeutics. On our opinion, the future of targeted delivery of drugs, nucleic acids, and other substances belongs to the site-targeted multifunctional and stimuli-based nanoparticles with controlled release. Targeting of nanocarriers to the disease site enhance the efficacy of the treatment by delivering more therapeutics specifically to the affected cells and substantially limiting adverse side effects upon healthy organs, tissues, and cells.
format Online
Article
Text
id pubmed-7904578
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-79045782022-02-01 Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery Majumder, Joydeb Minko, Tamara Expert Opin Drug Deliv Article INTRODUCTION: Nanocarrier-based delivery systems offer multiple benefits to overcome limitations of the traditional drug dosage forms, such as protection of the drug, enhanced bioavailability, targeted delivery to disease site, etc. Nanocarriers have exhibited tremendous successes in targeted delivery of therapeutics to the desired tissues and cells with improved bioavailability, high drug loading capacity, enhanced intracellular delivery, and better therapeutic effect. A specific design of stimuli-responsive nanocarriers allows for changing their structural and physicochemical properties in response to exogenous and endogenous stimuli. These nanocarriers show a promise in site specific controlled release of therapeutics under certain physiological conditions or external stimuli. AREAS COVERED: This review highlights recent progresses on the multifunctional and stimuli-sensitive nanocarriers for targeted therapeutic drug delivery applications. EXPERT OPINION: The progress from single functional to multifunctional nanocarriers has shown tremendous potential for targeted delivery of therapeutics. On our opinion, the future of targeted delivery of drugs, nucleic acids, and other substances belongs to the site-targeted multifunctional and stimuli-based nanoparticles with controlled release. Targeting of nanocarriers to the disease site enhance the efficacy of the treatment by delivering more therapeutics specifically to the affected cells and substantially limiting adverse side effects upon healthy organs, tissues, and cells. 2020-10-08 2021-02 /pmc/articles/PMC7904578/ /pubmed/32969740 http://dx.doi.org/10.1080/17425247.2021.1828339 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Article
Majumder, Joydeb
Minko, Tamara
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
title Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
title_full Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
title_fullStr Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
title_full_unstemmed Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
title_short Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
title_sort multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904578/
https://www.ncbi.nlm.nih.gov/pubmed/32969740
http://dx.doi.org/10.1080/17425247.2021.1828339
work_keys_str_mv AT majumderjoydeb multifunctionalandstimuliresponsivenanocarriersfortargetedtherapeuticdelivery
AT minkotamara multifunctionalandstimuliresponsivenanocarriersfortargetedtherapeuticdelivery